The latest tech deal, Microsoft’s second-biggest after its $26.2 billion LinkedIn purchase in 2016, follows heightened regulatory scrutiny of “killer acquisitions” whereby tech giants buy and shut down nascent start-ups and potential rivals.
Microsoft announced the Nuance deal, which would boost its presence in cloud services for healthcare, in April and it has already received regulatory approval in the United States and Australia, without remedies given.
Known for its pioneering speech technology and helping launch Apple’s Siri virtual assistant, Nuance serves 77% of US hospitals.
The European Commission, which is scheduled to decide on Microsoft’s proposed Nuance purchase by Dec. 21, declined to comment. Microsoft declined to comment.
Microsoft has also been in preliminary discussions with Britain’s CMA antitrust agency ahead of a formal request for approval of the Nuance deal, the sources said. The company’s request is expected to be filed in January, they added.
-
“ETtech is a sharply-focused lens that brings alive India’s tech businesses & dynamic world of startups”
Kunal Bahl, Co-Founder & CEO, Snapdeal
-
“I read ETtech for in-depth stories on technology companies”
Ritesh Agarwal, Founder & CEO, Oyo
-
“I read ETtech to understand trends & the larger India technology space, everyday”
Deepinder Goyal, Co-founder & CEO, Zomato
A CMA spokesperson said it does not speculate on which cases it might investigate. Its website does not list Microsoft’s proposed Nuance takeover as one it is looking at.
The European Commission last month asked customers and competitors to list concerns about the deal, such as whether Microsoft could favour Nuance over its competitors or unfairly bundle its offerings, Reuters reported exclusively on Tuesday.
The outreach was the most extensive by an antitrust authority reviewing the deal, a source said.
Tech companies have ramped up acquisitions of AI-focused firms to try to stay ahead of competitors as more integrate this technology into their products and services.
